Randomized trial explores the interaction of ChR2 with gold nanoclusters, suggesting enhanced optogenetic control.
Hybrid light-matter platforms that combine biomolecular photochemistry with engineered electromagnetic fields offer a promising, largely unexplored way to extend optogenetic control beyond the limits of native chromophores. Channelrhodopsin-2 (ChR2), a...
No takes yet. Share an insight, caveat, or question.
Messina et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: